These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 19912998)
1. Differential temporal changes in brain and gut substance P mRNA expression throughout the time-course of cisplatin-induced vomiting in the least shrew (Cryptotis parva). Dey D; Abad J; Ray AP; Darmani NA Brain Res; 2010 Jan; 1310():103-12. PubMed ID: 19912998 [TBL] [Abstract][Full Text] [Related]
2. Cisplatin causes over-expression of tachykinin NK(1) receptors and increases ERK1/2- and PKA- phosphorylation during peak immediate- and delayed-phase emesis in the least shrew (Cryptotis parva) brainstem. Darmani NA; Dey D; Chebolu S; Amos B; Kandpal R; Alkam T Eur J Pharmacol; 2013 Jan; 698(1-3):161-9. PubMed ID: 23001014 [TBL] [Abstract][Full Text] [Related]
3. Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists. Darmani NA; Wang Y; Abad J; Ray AP; Thrush GR; Ramirez J Brain Res; 2008 Jun; 1214():58-72. PubMed ID: 18471804 [TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide causes activation of protein kinase A (PKA) in the brainstem of vomiting least shrews (Cryptotis parva). Alkam T; Chebolu S; Darmani NA Eur J Pharmacol; 2014 Jan; 722():156-64. PubMed ID: 24513510 [TBL] [Abstract][Full Text] [Related]
5. Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva). Ray AP; Chebolu S; Darmani NA Pharmacol Biochem Behav; 2009 Nov; 94(1):211-8. PubMed ID: 19699757 [TBL] [Abstract][Full Text] [Related]
6. A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: evidence from the least shrew. Darmani NA; Crim JL; Janoyan JJ; Abad J; Ramirez J Brain Res; 2009 Jan; 1248():40-58. PubMed ID: 19022231 [TBL] [Abstract][Full Text] [Related]
7. The anti-asthmatic drug pranlukast suppresses the delayed-phase vomiting and reverses intracellular indices of emesis evoked by cisplatin in the least shrew (Cryptotis parva). Darmani NA; Chebolu S; Zhong W; Kim WD; Narlesky M; Adams J; Dong F Eur J Pharmacol; 2017 Aug; 809():20-31. PubMed ID: 28501575 [TBL] [Abstract][Full Text] [Related]
8. The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva). Zhong W; Darmani NA Neurochem Int; 2020 Jan; 132():104603. PubMed ID: 31738972 [TBL] [Abstract][Full Text] [Related]
9. Delta 9-tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew. Ray AP; Griggs L; Darmani NA Behav Brain Res; 2009 Jan; 196(1):30-6. PubMed ID: 18721829 [TBL] [Abstract][Full Text] [Related]
10. Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva). Darmani NA; Chebolu S; Amos B; Alkam T Pharmacol Biochem Behav; 2011 Oct; 99(4):573-9. PubMed ID: 21683089 [TBL] [Abstract][Full Text] [Related]
11. Additive antiemetic efficacy of low-doses of the cannabinoid CB(1/2) receptor agonist Δ(9)-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva). Darmani NA; Chebolu S; Zhong W; Trinh C; McClanahan B; Brar RS Eur J Pharmacol; 2014 Jan; 722():147-55. PubMed ID: 24157976 [TBL] [Abstract][Full Text] [Related]
12. Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis. Darmani NA J Neural Transm (Vienna); 1998; 105(10-12):1143-54. PubMed ID: 9928884 [TBL] [Abstract][Full Text] [Related]
13. Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew. Darmani NA; McClanahan BA; Trinh C; Petrosino S; Valenti M; Di Marzo V Neuropharmacology; 2005 Sep; 49(4):502-13. PubMed ID: 15921709 [TBL] [Abstract][Full Text] [Related]
14. Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva). Darmani NA; Zhong W; Chebolu S; Vaezi M; Alkam T Eur J Pharmacol; 2014 Jan; 722():2-12. PubMed ID: 24513517 [TBL] [Abstract][Full Text] [Related]
15. A histologically derived stereotaxic atlas and substance P immunohistochemistry in the brain of the least shrew (Cryptotis parva) support its role as a model organism for behavioral and pharmacological research. Ray AP; Darmani NA Brain Res; 2007 Jul; 1156():99-111. PubMed ID: 17540350 [TBL] [Abstract][Full Text] [Related]
16. RNA sequencing least shrew ( Irizarry KJL; Zhong W; Sun Y; Kronmiller BA; Darmani NA Front Genet; 2023; 14():975087. PubMed ID: 36865388 [TBL] [Abstract][Full Text] [Related]
17. Broad-spectrum antiemetic efficacy of the L-type calcium channel blocker amlodipine in the least shrew (Cryptotis parva). Zhong W; Chebolu S; Darmani NA Pharmacol Biochem Behav; 2014 May; 120():124-32. PubMed ID: 24631485 [TBL] [Abstract][Full Text] [Related]
18. Differential and additive suppressive effects of 5-HT3 (palonosetron)- and NK1 (netupitant)-receptor antagonists on cisplatin-induced vomiting and ERK1/2, PKA and PKC activation. Darmani NA; Zhong W; Chebolu S; Mercadante F Pharmacol Biochem Behav; 2015 Apr; 131():104-11. PubMed ID: 25687374 [TBL] [Abstract][Full Text] [Related]
19. Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews. Eiseman JL; Beumer JH; Rigatti LH; Strychor S; Meyers K; Dienel S; Horn CC Cancer Chemother Pharmacol; 2015 Jan; 75(1):143-52. PubMed ID: 25398697 [TBL] [Abstract][Full Text] [Related]
20. Thapsigargin-induced activation of Ca(2+)-CaMKII-ERK in brainstem contributes to substance P release and induction of emesis in the least shrew. Zhong W; Chebolu S; Darmani NA Neuropharmacology; 2016 Apr; 103():195-210. PubMed ID: 26631534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]